Dual antiplatelet therapy and the severity risk of lower intestinal bleeding

Dual antiplatelet therapy and the severity risk of lower intestinal bleeding

Background: Dual antiplatelet (Plt) therapy with aspirin and clopidogrel is recommended for up to 1 year following acute coronary syndrome. Many of these cardiac patients are also on anithrombotic therapy like warfarin. Lower gastrointestinal bleeding (LGIB) is the main adverse event of this treatme...

Full description

Bibliographic Details
Main Authors: Neal Carlin, Fady Asslo, Raymund Sison, Hamid Shaaban, Walid Baddoura, Faiza Manji, Joseph Depasquale
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Emergencies, Trauma and Shock
Subjects:
Antiplatelet
antithrombotic
lower gastrointestinal bleeding
Online Access:http://www.onlinejets.org/article.asp?issn=0974-2700;year=2017;volume=10;issue=3;spage=98;epage=102;aulast=Carlin

Internet

http://www.onlinejets.org/article.asp?issn=0974-2700;year=2017;volume=10;issue=3;spage=98;epage=102;aulast=Carlin

Similar Items